Evidence map›Paper›PMID 34576809›Full record

ArticleMicroorganisms2021

In Vivo Biofilm Formation of Pathogenic

Kerstin Ackermann, Rebecca Kenngott, Monica Settles, Hartmut Gerhards, Johann Maierl, Bettina Wollanke

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Applied and environmental microbiology · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Comparative genomics ofFrontiers in microbiology · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Host and Species-Specificities of Pattern Recognition Receptors Upon Infection WithFrontiers in cellular and infection microbiology · 2022
    Review
  11. Frontiers in immunology · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kerstin AckermannEquine Clinic, Clinical Department, Ludwig-Maximilians-University, 80539 Munich, Germany.
Rebecca KenngottInstitute for Anatomy, Histology and Embryology, Department of Veterinary Science, Ludwig-Maximilians-University, 80539 Munich, Germany.
Monica SettlesInstitute for Anatomy, Histology and Embryology, Department of Veterinary Science, Ludwig-Maximilians-University, 80539 Munich, Germany.
Hartmut GerhardsEquine Clinic, Clinical Department, Ludwig-Maximilians-University, 80539 Munich, Germany.
Johann MaierlInstitute for Anatomy, Histology and Embryology, Department of Veterinary Science, Ludwig-Maximilians-University, 80539 Munich, Germany.
Bettina WollankeEquine Clinic, Clinical Department, Ludwig-Maximilians-University, 80539 Munich, Germany.ORCID 0000-0002-6767-9615
Ludwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Equine recurrent uveitis (ERU) causes painful inflammatory attacks and oftentimes blindness in the affected eyes. The disease is considered a late sequela of systemic leptospirosis. The most effective therapy is the surgical removal of the vitreous (vitrectomy), which is not only therapeutic, but provides vitreous material that can be assessed diagnostically. For example, the

Indexed as

antibiotic tolerancebiofilm infectionequine recurrent uveitis (ERU)immune toleranceimmunohistochemistryin vivo biofilm formationLeptospira spp.vitreous humorWarthin-Starry silver stain

Identifiers

PMID34576809
PMCPMC8464839
OpenAlexW3198592702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.